It recommends that clinicians discuss the potential benefits and harms of PSA screening with these men for shared decision-making.
"We are more confident about the benefits of screening", said Bibbins-Domingo. "In many cases, these groups may not access the healthcare system and have dialogue with their medical professionals about PSA test among other issues".
After this Wednesday the Preventive Services Task Force presented its latest draft, many have shown its disconformity with the recommendations.
PSA screening to detect the most common male cancer is among the most heated topics in men's health.
Urologists had criticized the panel's 2012 advice against the testing, saying such an approach would lead to a reduction in screening and an increase in deaths. Ultimately the health panel claims that men between the ages of 55 to 69 should talk to their physician about the advantages and disadvantages of the PSA test. Marsha Blackburn, R-Tenn., and Bobby L. Rush, D-Ill., introduced legislation to "reform" the independent panel and add specialists to the prevention experts appointed by a federal health agency. The goal is to find cancer at an early, treatable stage. But it does say they should know their risks are higher.
With the update in recommendations, the dispute over PSA testing is likely to continue. For example, new data has shown that most prostate cancer cases grow slowly or do not grow at all.
Prostate cancer is one of the most common types among men in the USA; almost 13 percent will be diagnosed with it over the course of their lifetimes, according to the National Cancer Institute. "These results give us confidence that we really have the full picture of the potential benefits of screening", says Bibbins-Domingo.
Susan Rice may have committed a crime, Trump says without providing evidence
Rice herself has publicly denied any wrongdoing. "He's a person I know well - he is a good person", Trump said. Meanwhile, President Donald Trump told the New York Times on Wednesday that Rice may have committed a crime.
In a grade D recommendation, the USPSTF continued to discourage PSA screening in men aged 70 and older. Instead of subjecting themselves to the potential harms of biopsies and treatment, they instead worked with their doctors to receive more regular checkups and monitoring of their cancer and only started treatment if the tumors developed. For many men, however, prostate cancer is slow-growing and takes many years to become life-threatening.
Schaeffer, who treated the actor Ben Stiller for aggressive prostate cancer, led a controversial 2016 study that found cases of metastatic prostate cancer - the type that has started to spread in the body - almost doubled in men aged 55 to 69 since 2004. But many men can live with the disease for years without its causing serious illness. African-American men, men with a family history of the disease, and men exposed to Agent Orange and some other chemicals are at greater risk.
There are other doctors who have said this is a complicated conversation that you're asking people to have with their doctors, doctors don't have a lot of time to talk their patients, and that they worry that these guidelines will be blanket everybody get a PSA test, and that then we will see all of these negative side effects.
William Nelson, director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, said the guideline shift reflects the increased use of active surveillance for low-risk prostate cancer.
According to the task force, one of the studies helped them on the making of the new guideline was published back in last year's October.
But the PSA test offers a small potential for benefit - with clear potential for harm. Some men who are concerned about prostate cancer will elect to be screened, and others who are less concerned will not; doctors should support either decision. "The newer recommendation should empower men to be proactive about learning about the benefits and risks of screening and not avoid asking about it because their personal physician is not a believer in screening and never even broaches the subject; men should ask for the facts and not be shy about asking to have a PSA ordered if they feel it's in their interest to do so".
The draft recommendation and evidence reviews are posted for public comment for consideration in the final recommendation and evidence review.